You just read:

Optina Diagnostics Receives Breakthrough Device Designation from U.S. FDA for a Retinal Imaging Platform to Aid in the Diagnosis of Alzheimer's Disease

News provided by

Optina Diagnostics

May 08, 2019, 12:14 ET